Mapping of immunoreactive sites of pneumococcal pneumolysin by use of synthetic peptides.
In the search for better diagnostic tools and improved vaccines against pneumococcal diseases, continuous antigenic sites of the pneumococcal pneumolysin molecule were identified with partially overlapping synthetic peptides. Peptides were derived from the predicted amino acid sequence according to the known DNA sequence of pneumolysin. The immunoreactivities of the peptides were studied by enzyme immunoassay with seven human serum samples and three rabbit hyperimmune serum samples. Two immunoreactive sites in the overlapping peptides at the amino-terminal end of the pneumolysin molecule were identified in this study. Two common immunoreactive sites for both human and rabbit sera were demonstrated.
National Public Health Institute, Helsinki, Finland.
P
P
Salo
A
A
Närvänen
M
M
Leinonen
D000595:Amino Acid Sequence; D000818:Animals; D001426:Bacterial Proteins; D003603:Cytotoxins / Q000276:immunology*; D006801:Humans; D008969:Molecular Sequence Data; D010446:Peptide Fragments / Q000276:immunology*; D011817:Rabbits; D016415:Sequence Alignment; D013301:Streptolysins / Q000737:chemistry / Q000276:immunology*; D013329:Structure-Activity Relationship
D001426:Bacterial Proteins; D003603:Cytotoxins; D010446:Peptide Fragments; D013301:Streptolysins; C032290:plY protein, Streptococcus pneumoniae; C025964:streptolysin O